Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Completed · Phase 2

Conditions studied: Metastatic Androgen Independent Prostate Cancer

In brief

This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)

Key facts

Study ID

NCT00849290

Run by

Dendreon

People needed

113

Starts

2004-04-01

Expected to finish

2009-04-01

Last updated by the study team

2023-11-29

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Objective disease progression
• Subjects must have been enrolled in the APC-Placebo arm of D9902B (NCT00065442)

You may not qualify if…

• Infection requiring IV antibiotics
• Treatment with anticancer interventions within 14 days prior to enrollment
• Any medical condition which could compromise the study's objectives (discretion from sponsor)

Where it is running

• USC Keck School of Medicine — Los Angeles, California, United States
• Sutter Cancer Center — Sacramento, California, United States
• Kaiser Permanente Medical Group — San Diego, California, United States
• Sharp HealthCare — San Diego, California, United States
• UCSF Cancer Center — San Francisco, California, United States
• Helen F. Graham Cancer Center — Newark, Delaware, United States
• Lombardi Cancer Center — Washington D.C., District of Columbia, United States
• Walter Reid Army Medical Center — Washington D.C., District of Columbia, United States
• Miami Cancer Center — Miami, Florida, United States
• Hematology/Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida, United States
• Georgia Urology, P.A. — Atlanta, Georgia, United States
• Midwest Prostate & Urology Health Center — Chicago, Illinois, United States
• Loyola University — Maywood, Illinois, United States
• Lutheran General Cancer Center — Park Ridge, Illinois, United States
• Indiana University — Indianapolis, Indiana, United States
• Myron I Murdock MD LLC — Greenbelt, Maryland, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• Lahey Clinic (Department of Urology) — Burlington, Massachusetts, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Nevada Cancer Institute — Las Vegas, Nevada, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Associates in Urology, LLC — West Orange, New Jersey, United States
• Albany Regional Cancer Center — Albany, New York, United States
• UCLA — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.